三鑫医疗：接受宏利基金调研

Group 1 - The core viewpoint of the article is that Sanxin Medical (SZ 300453) held a research meeting with Manulife Fund and Wanjia Fund on August 21, 2025, where company executives addressed investor inquiries [1] - For the first half of 2025, Sanxin Medical's revenue composition was 99.78% from the medical device industry and 0.22% from other businesses [1]